Chitosan layered gold nanorods as synergistic therapeutics for photothermal ablation and gene silencing in triple-negative breast cancer

Acta Biomaterialia

Volumn 25, Issue , 2015, Pages 194-204

  Yang, Zhizhou ^a   Liu, Tengfei ^b   Xie, Yan ^c   Sun, Zhaorui ^a   Liu, Hongmei ^a   Lin, Jinfeng ^a   Liu, Changjing ^a   Mao, Zong Wan ^d   Nie, Shinan ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

Breast cancer; Chitosan; Gold nanorods; Photothermal ablation; Small interfering RNA

Indexed keywords

ABLATION; CELL PROLIFERATION; DISEASES; GENE THERAPY; GENETIC ENGINEERING; GOLD; NANORIBBONS; NANORODS; OPTICAL PROPERTIES; PLASMONS; RNA; TUMORS;

BREAST CANCER; DELIVERY SYSTEMS; DELIVERY VEHICLE; GENE SILENCING; GOLD NANOROD; PHOTOTHERMAL ABLATION; SMALL INTERFERING RNA; TARGET CELLS; TARGET TISSUES; TRIPLE-NEGATIVE BREAST CANCERS;

CHITOSAN;

CHITOSAN; GOLD NANOROD; PYRUVATE KINASE; RIBONUCLEASE; SMALL INTERFERING RNA; GOLD; NANOTUBE;

ABLATION THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONFOCAL MICROSCOPY; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; INTERNALIZATION; MOUSE; NONHUMAN; ONCOGENE; PHOTOTHERMAL ABLATION; PRIORITY JOURNAL; TARGET CELL; TRIPLE NEGATIVE BREAST CANCER; CELL MOTION; CELL SURVIVAL; CHEMISTRY; ENDOCYTOSIS; GENE EXPRESSION REGULATION; GENE TRANSFER; INTRACELLULAR SPACE; METABOLISM; PATHOLOGY; PHOTOTHERAPY; THERMOTHERAPY; TISSUE DISTRIBUTION; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELL LINE; ULTRASTRUCTURE;

CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CHITOSAN; ENDOCYTOSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENE TRANSFER TECHNIQUES; GOLD; HUMANS; HYPERTHERMIA, INDUCED; INTRACELLULAR SPACE; NANOTUBES; PHOTOTHERAPY; TISSUE DISTRIBUTION; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84940898208     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2015.07.026     Document Type: Article

References (25)

1. L. Hutchinson Breast cancer: challenges, controversies, breakthroughs Nat. Rev. Clin. Oncol. 7 2010 669 670
2. H. Shen, V. Mittal, M. Ferrari, and J. Chang Delivery of gene silencing agents for breast cancer therapy Breast Cancer Res. 15 2013 205
3. C.A. Hudis, and L. Gianni Triple-negative breast cancer: an unmet medical need Oncologist 16 2011 1 11
4. W.D. Foulkes, I.E. Smith, and J.S. Reis-Filho Triple-negative breast cancer N. Engl. J. Med. 363 2010 1938 1948
5. L. Carey, E. Winer, G. Viale, D. Cameron, and L. Gianni Triple-negative breast cancer: disease entity or title of convenience? Nat. Rev. Clin. Oncol. 7 2010 683 692
6. R. Xu, Y. Huang, J. Mai, G. Zhang, X. Guo, X. Xia, and et al. Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy Small 9 2013 1799 1808
7. A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, and C.C. Mello Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 1998 806 811
8. S. Guo, and L. Huang Nanoparticles escaping RES and endosome: challenges for siRNA delivery for cancer therapy J. Nanomater. 2011 2011 1 12
9. W. Wei, P.-P. Lv, X.-M. Chen, Z.-G. Yue, Q. Fu, S.-Y. Liu, and et al. Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression Biomaterials 34 2013 3912 3923
10. M. Zheng, D. Librizzi, A. KIlIç, Y. Liu, H. Renz, O.M. Merkel, and et al. Enhancing in vivo circulation and siRNA delivery with biodegradable polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol) copolymers Biomaterials 33 2012 6551 6558
11. D. Ma Enhancing endosomal escape for nanoparticle mediated siRNA delivery Nanoscale 6 2014 6415 6425
12. J. Shen, R. Xu, J. Mai, H.-C. Kim, X. Guo, G. Qin, and et al. High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics ACS Nano 7 2013 9867 9880
13. J. Shen, H.-C. Kim, C. Mu, E. Gentile, J. Mai, J. Wolfram, and et al. Multifunctional gold nanorods for siRNA gene silencing and photothermal therapy Adv. Healthcare Mater. 3 2014 1629 1637
14. L. Vigderman, B.P. Khanal, and E.R. Zubarev Functional gold nanorods: synthesis, self-assembly, and sensing applications Adv. Mater. 24 2012 4811 4841
15. L. Dykman, and N. Khlebtsov Gold nanoparticles in biomedical applications: recent advances and perspectives Chem. Soc. Rev. 41 2012 2256 2282
16. J. Pérez-Juste, I. Pastoriza-Santos, L.M. Liz-Marzán, and P. Mulvaney Gold nanorods: synthesis, characterization and applications Coord. Chem. Rev. 249 2005 1870 1901
17. C.J. Bishop, S.Y. Tzeng, and J.J. Green Degradable polymer-coated gold nanoparticles for co-delivery of DNA and siRNA Acta Biomater. 11 2015 393 403
18. T. Patino, U. Mahajan, R. Palankar, N. Medvedev, J. Walowski, M. Munzenberg, and et al. Multifunctional gold nanorods for selective plasmonic photothermal therapy in pancreatic cancer cells using ultra-short pulse near-infrared laser irradiation Nanoscale 7 2015 5328 5337
19. E. Locatelli, I. Monaco, and M. Comes Franchini Surface modifications of gold nanorods for applications in nanomedicine RSC Adv. 5 2015 21681 21699
20. K.A. Whitehead, R. Langer, and D.G. Anderson Knocking down barriers: advances in siRNA delivery Nat. Rev. Drug Discov. 8 2009 129 138
21. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discov. 9 2010 615 627
22. J. Shen, H.-C. Kim, H. Su, F. Wang, J. Wolfram, D. Kirui, and et al. Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics Theranostics 4 2014 487
23. J.-M. Li, M.-X. Zhao, H. Su, Y.-Y. Wang, C.-P. Tan, L.-N. Ji, and et al. Multifunctional quantum-dot-based siRNA delivery for HPV18 E6 gene silence and intracellular imaging Biomaterials 32 2011 7978 7987
24. H. Meng, W.X. Mai, H. Zhang, M. Xue, T. Xia, S. Lin, and et al. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo ACS Nano 7 2013 994 1005
25. A.M. Chen, M. Zhang, D. Wei, D. Stueber, O. Taratula, T. Minko, and et al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells Small 5 2009 2673 2677